• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Rafael Holdings Inc (NY: RFL )

    1.780 -0.050 (-2.73%)
    Streaming Delayed Price Updated: 10:10 AM EST, Nov 4, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Press Releases about Rafael Holdings Inc

    SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CDE, SMC, COFS, RFL on Behalf of Shareholders
    From Halper Sadeh LLC
    Via GlobeNewswire
    SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates BTTR, RVNC, ARC, RFL on Behalf of Shareholders
    From Halper Sadeh LLC
    Via GlobeNewswire
    SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates COFS, ARC, NBY, RFL on Behalf of Shareholders
    From Halper Sadeh LLC
    Via GlobeNewswire
    BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: CrossFirst Bankshares, Inc. (Nasdaq - CFB), Arch Resources, Inc. (NYSE - ARCH), Cyclo Therapeutics, Inc. (Nasdaq - CYTH), Vector Group Ltd. (NYSE - VGR)
    From Brodsky & Smith LLC
    Via GlobeNewswire
    BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: CrossFirst Bankshares, Inc. (Nasdaq - CFB), Arch Resources, Inc. (NYSE - ARCH), Cyclo Therapeutics, Inc. (Nasdaq - CYTH), Vector Group Ltd. (NYSE - VGR)
    From Brodsky & Smith LLC
    Via GlobeNewswire
    RFL Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Rafael Holdings, Inc. Is Fair to Shareholders
    From Halper Sadeh LLC
    Via Business Wire
    Rafael Holdings and Cyclo Therapeutics Enter Into a Definitive Merger Agreement
    From Cyclo Therapeutics, Inc.
    Via Business Wire
    Rafael Holdings and Cyclo Therapeutics Enter into a Definitive Merger Agreement
    From Rafael Holdings, Inc.; Cyclo Therapeutics
    Via GlobeNewswire
    Rafael Holdings Reports Third Quarter Fiscal 2024 Financial Results
    Strategically focused on generating shareholder value by advancing our portfolio and identifying attractive investment opportunities with substantive upside potential 
    From Rafael Holdings, Inc.
    Via GlobeNewswire
    Cyclo Therapeutics Achieves Landmark Milestone with Completion of Enrollment of Last Patient in Phase 3 Pivotal TransportNPC™ Trial of Niemann-Pick Type C1
    From Cyclo Therapeutics, Inc.
    Via Business Wire
    Rafael Holdings Reports Second Quarter Fiscal 2024 Financial Results
    From Rafael Holdings, Inc.
    Via GlobeNewswire
    Rafael Holdings Reports First Quarter Fiscal 2024 Financial Results
    Company remains focused on generating shareholder value by advancing our portfolio and identifying attractive opportunities for strategic investments 
    From Rafael Holdings, Inc.
    Via GlobeNewswire
    Cyclo Therapeutics Reports Third Quarter 2023 Financial Results
    From Cyclo Therapeutics, Inc.
    Via Business Wire
    Rafael Holdings Reports Fourth Quarter and Full Year Fiscal 2023 Financial Results
    Company positions itself to generate value for its stockholders by curtailing expenses while increasing investment in strategic opportunities 
    From Rafael Holdings, Inc.
    Via GlobeNewswire
    Cyclo Therapeutics Reports Second Quarter 2023 Financial Results
    From Cyclo Therapeutics, Inc.
    Via Business Wire
    Cyclo Therapeutics Announces Closing of $5.0 Million Private Placement with Rafael Holdings, Inc.
    From Cyclo Therapeutics, Inc.
    Via Business Wire
    Rafael Holdings Reports Third Quarter Fiscal 2023 Financial Results and Provides Business Update
    Since the end of the third quarter, we made an initial $2.1 million investment in Cyclo Therapeutics, Inc. (Nasdaq: CYTH) and have an agreement to increase our investment by $5 million 
    From Rafael Holdings, Inc.
    Via GlobeNewswire
    Cyclo Therapeutics Announces Execution of Definitive Agreement with Rafael Holdings, Inc. Providing for $5.0 Million of Additional Funding Via a Private Placement
    From Cyclo Therapeutics, Inc.
    Via Business Wire
    Cyclo Therapeutics Provides Business Update and Reports First Quarter 2023 Financial Results
    From Cyclo Therapeutics, Inc.
    Via Business Wire
    Cyclo Therapeutics Announces Closing of Strategic Investment Through a $2.1 Million Private Placement from Rafael Holdings, Inc. (NYSE:RFL)
    From Cyclo Therapeutics, Inc.
    Via Business Wire
    Rafael Holdings Announces up to $5 Million Share Repurchase Program
    Announces expanded search for strategic opportunities beyond biopharma 
    From Rafael Holdings, Inc.
    Via GlobeNewswire
    Rafael Holdings Reports Second Quarter Fiscal 2023 Financial Results
    From Rafael Holdings, Inc.
    Via GlobeNewswire
    Rafael Holdings Reports First Quarter Fiscal 2023 Financial Results
    From Rafael Holdings, Inc.
    Via GlobeNewswire
    Rafael Holdings to Focus on Strategic Business Development Initiatives and Curtail Early Stage Development Activities
    From Rafael Holdings, Inc.
    Via GlobeNewswire
    Rafael Holdings Reports Fourth Quarter Fiscal 2022 Financial Results
    From Rafael Holdings, Inc.
    Via GlobeNewswire
    Cornerstone Pharmaceuticals Initiates Phase 1 Trial of CPI-613® (devimistat) in Combination with Chemoradiation for the Treatment of Advanced Pancreatic Cancer
    Clinical program advancement represents key milestone for Cornerstone underscoring its commitment to the development of lead compound, devimistat, in pancreatic cancer 
    From Cornerstone Pharmaceuticals
    Via GlobeNewswire
    SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates RFL, SAFM, SNR; Shareholders are Encouraged to Contact the Firm
    NEW YORK, NY / ACCESSWIRE / September 1, 2021 / Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies: Rafael Holdings, Inc. (NYSE:RFL) concerning... 
    From Halper Sadeh LLP
    Via AccessWire
    Topics Fraud
    Exposures Legal
    RAFAEL (RFL) STOCKHOLDER ALERT - Andrews & Springer LLC Is Seeking More Cash for Shareholders of Rafael Holdings, Inc.
    From Andrews & Springer LLC
    Via Business Wire
    RAFAEL HOLDINGS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Rafael Holdings, Inc. - RFL
    From Kahn Swick & Foti, LLC
    Via Business Wire
    Rafael Holdings Merger Investigation: Halper Sadeh LLP Announces Investigation Into Whether the Merger of Rafael Holdings, Inc. Is Fair to Shareholders; Investors Are Encouraged to Contact the Firm – RFL
    From Halper Sadeh LLP
    Via Business Wire
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.